APA
Mendizabal M., Haddad L., Gallardo P. E., Ferrada A., Soza A. A., Adrover R., Aravena E., Roblero J. P., Prieto J., Vujacich C., Romero G., Muñoz A., Anders M., Hernández N., Coccozella D., Gruz F., Reggiardo M. V., Ruf A. E., Varón A., Cartier M., Pérez Ravier R., Ridruejo E., Peralta M., Poncino D., Vorobioff J., Aballay Soteras G. & Silva M. O. (20180320). Ombitasvir/paritaprevir/ritonavir/dasabuvir ± ribavirin is safe and effective in HCV-infected patients in a real-life cohort from Latin America. : Journal of medical virology.
Chicago
Mendizabal Manuel, Haddad Leila, Gallardo Patricia E, Ferrada Alejandro, Soza Alejandro A, Adrover Raul, Aravena Edmundo, Roblero Juan P, Prieto Jhon, Vujacich Claudia, Romero Gustavo, Muñoz Alberto, Anders Margarita, Hernández Nelia, Coccozella Daniel, Gruz Fernando, Reggiardo Maria V, Ruf Andres E, Varón Adriana, Cartier Mariano, Pérez Ravier Roberto, Ridruejo Ezequiel, Peralta Mirta, Poncino Daniel, Vorobioff Julio, Aballay Soteras Gabriel and Silva Marcelo O. 20180320. Ombitasvir/paritaprevir/ritonavir/dasabuvir ± ribavirin is safe and effective in HCV-infected patients in a real-life cohort from Latin America. : Journal of medical virology.
Harvard
Mendizabal M., Haddad L., Gallardo P. E., Ferrada A., Soza A. A., Adrover R., Aravena E., Roblero J. P., Prieto J., Vujacich C., Romero G., Muñoz A., Anders M., Hernández N., Coccozella D., Gruz F., Reggiardo M. V., Ruf A. E., Varón A., Cartier M., Pérez Ravier R., Ridruejo E., Peralta M., Poncino D., Vorobioff J., Aballay Soteras G. and Silva M. O. (20180320). Ombitasvir/paritaprevir/ritonavir/dasabuvir ± ribavirin is safe and effective in HCV-infected patients in a real-life cohort from Latin America. : Journal of medical virology.
MLA
Mendizabal Manuel, Haddad Leila, Gallardo Patricia E, Ferrada Alejandro, Soza Alejandro A, Adrover Raul, Aravena Edmundo, Roblero Juan P, Prieto Jhon, Vujacich Claudia, Romero Gustavo, Muñoz Alberto, Anders Margarita, Hernández Nelia, Coccozella Daniel, Gruz Fernando, Reggiardo Maria V, Ruf Andres E, Varón Adriana, Cartier Mariano, Pérez Ravier Roberto, Ridruejo Ezequiel, Peralta Mirta, Poncino Daniel, Vorobioff Julio, Aballay Soteras Gabriel and Silva Marcelo O. Ombitasvir/paritaprevir/ritonavir/dasabuvir ± ribavirin is safe and effective in HCV-infected patients in a real-life cohort from Latin America. : Journal of medical virology. 20180320.